Loading asset research
Neuphoria Therapeutics Inc. Common Stock
NEUPNasdaq · USD · StocksQuote as of · Exchange session not verified$3.65
-0.82%
Today
Next earnings call
The next call has not been scheduled by the current earnings provider.
EPS vs. consensus estimate
- Actual
- Estimate
Q3 25Q4 25Q 25Q 26
Revenue vs. consensus estimate
- Actual
- Estimate
Q3 25
EPS surprise history
Q4 25Q 26
Beat or met consensus in 33% of the last 3 reported quarters.
Previous reports
Values are converted from USD into your selected display currency. Actuals are drawn from SEC filings (XBRL) and Yahoo statements; estimates and surprises from Nasdaq where available.
| Fiscal period | Report date | Normalized EPS | EPS surprise | Revenue | Rev. surprise | Actions |
|---|---|---|---|---|---|---|
| Q 2026 | May 15, 2026 | -$0.09 / (-$0.56 est.) | +83.93% | 0 (unit unavailable) / (— est.) | — | Source |
| Q3 2026 | May 15, 2026 | -0.09 (unit unavailable) / (— est.) | — | — / (— est.) | — | — |
| Q 2025 | Nov 14, 2025 | -$4.41 / (-$0.55 est.) | -701.82% | 0 (unit unavailable) / (— est.) | — | Source |
| Q4 2025 | Sep 29, 2025 | -$5.79 / (-$0.56 est.) | -933.93% | — / (— est.) | — | Source |
| Q3 2025 | May 20, 2025 | $6.55 / (— est.) | — | $15M / (— est.) | — | Source |
| Q2 2025 | Feb 14, 2025 | -1.79 (unit unavailable) / (— est.) | — | 662,715 (unit unavailable) / (— est.) | — | — |
| Q1 2025 | Nov 14, 2024 | -0.62 (unit unavailable) / (— est.) | — | — / (— est.) | — | — |
| Q4 2024 | Sep 30, 2024 | -10.48 (unit unavailable) / (— est.) | — | — / (— est.) | — | — |
Regulatory filings
Company reports filed with the SEC.